Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

164 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Challenges and Approaches to Establishing Multi-Pathogen Serosurveillance: Findings from the 2023 Serosurveillance Summit.
Carcelen AC, Kong AC, Takahashi S, Hegde S, Jaenisch T, Chu M, Rochford R, Kostandova N, Gurley ES, Wesolowski A, Azman AS, van der Klis FRM, den Hartog G, Drakeley C, Heaney CD, Winter AK, Salje H, Rodriguez-Barraquer I, Leung DT, Njenga SM, Kagucia EW, Jambo KC, Wolter N, Charles RC, Saboyá-Díaz MI, Martin DL, Moss WJ. Carcelen AC, et al. Among authors: van der klis frm. Am J Trop Med Hyg. 2024 Sep 3;111(5):1145-1152. doi: 10.4269/ajtmh.24-0296. Print 2024 Nov 6. Am J Trop Med Hyg. 2024. PMID: 39226906 Free PMC article.
Induction of salivary antibody levels in Dutch adolescents after immunization with monovalent meningococcal serogroup C or quadrivalent meningococcal serogroup A, C, W and Y conjugate vaccine.
van Ravenhorst MB, den Hartog G, van der Klis FRM, van Rooijen DM, Sanders EAM, Berbers GAM. van Ravenhorst MB, et al. Among authors: van der klis frm, van rooijen dm. PLoS One. 2018 Apr 19;13(4):e0191261. doi: 10.1371/journal.pone.0191261. eCollection 2018. PLoS One. 2018. PMID: 29672552 Free PMC article. Clinical Trial.
Immune surveillance for vaccine-preventable diseases.
den Hartog G, van Binnendijk R, Buisman AM, Berbers GAM, van der Klis FRM. den Hartog G, et al. Among authors: van binnendijk r, van der klis frm. Expert Rev Vaccines. 2020 Apr;19(4):327-339. doi: 10.1080/14760584.2020.1745071. Epub 2020 Mar 29. Expert Rev Vaccines. 2020. PMID: 32223469 Free article. Review.
SARS-CoV-2-Specific Antibody Detection for Seroepidemiology: A Multiplex Analysis Approach Accounting for Accurate Seroprevalence.
den Hartog G, Schepp RM, Kuijer M, GeurtsvanKessel C, van Beek J, Rots N, Koopmans MPG, van der Klis FRM, van Binnendijk RS. den Hartog G, et al. Among authors: van binnendijk rs, van der klis frm, van beek j. J Infect Dis. 2020 Oct 1;222(9):1452-1461. doi: 10.1093/infdis/jiaa479. J Infect Dis. 2020. PMID: 32766833 Free PMC article.
Nationwide seroprevalence of SARS-CoV-2 and identification of risk factors in the general population of the Netherlands during the first epidemic wave.
Vos ERA, den Hartog G, Schepp RM, Kaaijk P, van Vliet J, Helm K, Smits G, Wijmenga-Monsuur A, Verberk JDM, van Boven M, van Binnendijk RS, de Melker HE, Mollema L, van der Klis FRM. Vos ERA, et al. Among authors: van binnendijk rs, van vliet j, van boven m, van der klis frm. J Epidemiol Community Health. 2020 Nov 28;75(6):489-95. doi: 10.1136/jech-2020-215678. Online ahead of print. J Epidemiol Community Health. 2020. PMID: 33249407 Free PMC article.
Persistence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 in Relation to Symptoms in a Nationwide Prospective Study.
den Hartog G, Vos ERA, van den Hoogen LL, van Boven M, Schepp RM, Smits G, van Vliet J, Woudstra L, Wijmenga-Monsuur AJ, van Hagen CCE, Sanders EAM, de Melker HE, van der Klis FRM, van Binnendijk RS. den Hartog G, et al. Among authors: van binnendijk rs, van vliet j, van boven m, van der klis frm, van den hoogen ll, van hagen cce. Clin Infect Dis. 2021 Dec 16;73(12):2155-2162. doi: 10.1093/cid/ciab172. Clin Infect Dis. 2021. PMID: 33624751 Free PMC article.
164 results